Mkts

AN2 Therapeutics, Inc.

NASDAQ: ANTX
$5.02+0.07 (+1.41%)
As of Nov 19, 9:36 AM ET

Key statistics

Day range
4.825.05
52-week range
1.007.19
Today
Open5.00
Previous close5.02
Volume—
Valuation
Market cap187.82M
P/E ratio—
EPS (TTM)-1.07
Income & risk
Dividend / yield—
Beta-0.92
Avg volume248.0K
Discussion

ANTX News

Stories mentioning ANTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development6,7436,8797,0003,2007,6905,3978,28712,149
Sales General & Admin
Total Operating Expenses10,5519,31610,0407,21611,5378,59814,01415,880
Operating Income (Loss)(10,551)(9,316)(10,040)(7,216)(11,537)(8,598)(14,014)(15,880)
Interest Income523.00605.00687.00754.00888.001,0761,2671,445
Interest Expense
Other Expense(1,267)1,2670.00
Pretax Income
Tax Provision
Net Income (Loss)(10,028)(8,710)(9,353)(6,462)(10,649)(7,522)(12,747)(14,435)
Earnings Per Share (Basic)(0.29)(0.29)(0.31)(0.21)(0.35)(0.25)(0.43)(0.48)
Earnings Per Share (Diluted)(0.29)(0.29)(0.31)(0.21)(0.35)(0.25)(0.43)(0.48)
Weighted Average Shares Outstanding (Basic)34,06030,21630,27630,17230,05429,82829,84129,825
Weighted Average Shares Outstanding (Diluted)34,06030,21630,27630,17230,05429,82829,84129,825

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ANTX

AN2 Therapeutics, Inc. (NASDAQ: ANTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANTX. It last traded at $5.02 (Nov 19, 2026, 9:36 AM ET), up 1.4% on the day. That gives AN2 Therapeutics a market capitalisation of $187.8M.

Over the past 52 weeks ANTX has traded between $1.00 and $7.19.

For the quarter ended Mar 31, 2026 it reported a net loss of $10.0M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$10.0M
Dec 31, 2025—-$8.7M
Sep 30, 2025—-$9.4M
Jun 30, 2025—-$6.5M

From AN2 Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…